메뉴 건너뛰기




Volumn 80, Issue 3, 2011, Pages 893-899

Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: A modeling study of dose dumping

Author keywords

Chemotherapy; Functional damage model; Lyman model; Pneumonitis risk; Radiotherapy

Indexed keywords

CELL KILLING; CHEMORADIOTHERAPY; CLINICAL SETTINGS; CRITICAL VOLUME; CYTOTOXIC; DATA SETS; FUNCTIONAL DAMAGE; HELICAL TOMOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; LYMAN MODEL; MODELING STUDIES; NON SMALL CELL LUNG CANCER; PNEUMONITIS RISK; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION PNEUMONITIS; RADIOTHERAPY ALONE; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT); THRESHOLD DOSE; TOMOTHERAPY; TREATMENT PLANS; UNIVERSITY OF WISCONSIN;

EID: 79957574394     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.12.073     Document Type: Article
Times cited : (32)

References (23)
  • 1
    • 36849079824 scopus 로고    scopus 로고
    • Intensity-Modulated Radiation Therapy: Supportive Data for Prostate Cancer
    • DOI 10.1016/j.semradonc.2007.09.007, PII S1053429607000793, Advances in the Management of Prostate Cancer
    • O. Cahlon, M. Hunt, and M.J. Zelefsky Intensity-modulated radiation therapy: Supportive data for prostate cancer Semin Radiat Oncol 18 2008 48 57 (Pubitemid 350235956)
    • (2008) Seminars in Radiation Oncology , vol.18 , Issue.1 , pp. 48-57
    • Cahlon, O.1    Hunt, M.2    Zelefsky, M.J.3
  • 2
    • 33847183937 scopus 로고    scopus 로고
    • Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control
    • G.O. De Meerleer, V.H. Fonteyne, and L. Vakaet Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control Radiother Oncol 82 2007 160 166
    • (2007) Radiother Oncol , vol.82 , pp. 160-166
    • De Meerleer, G.O.1    Fonteyne, V.H.2    Vakaet, L.3
  • 4
    • 56349105562 scopus 로고    scopus 로고
    • The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis
    • D.I. Rosenthal, T.R. Mendoza, and M.S. Chambers The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis Int J Radiat Oncol Biol Phys 72 2008 1355 1361
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 1355-1361
    • Rosenthal, D.I.1    Mendoza, T.R.2    Chambers, M.S.3
  • 5
    • 57749169285 scopus 로고    scopus 로고
    • Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase i dose escalation study
    • J.B. Adkison, D. Khuntia, and S.M. Bentzen Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study Technol Cancer Res Treat 7 2008 441 447
    • (2008) Technol Cancer Res Treat , vol.7 , pp. 441-447
    • Adkison, J.B.1    Khuntia, D.2    Bentzen, S.M.3
  • 6
    • 33847640529 scopus 로고    scopus 로고
    • Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions
    • DOI 10.1038/ncponc0744, PII NCPONC0744
    • S.M. Bentzen, P.M. Harari, and J. Bernier Exploitable mechanisms for combining drugs with radiation: Concepts, achievements and future directions Nat Clin Pract Oncol 4 2007 172 180 (Pubitemid 46358854)
    • (2007) Nature Clinical Practice Oncology , vol.4 , Issue.3 , pp. 172-180
    • Bentzen, S.M.1    Harari, P.M.2    Bernier, J.3
  • 7
    • 29244465506 scopus 로고    scopus 로고
    • Biologic basis for combining drugs with radiation
    • DOI 10.1016/j.semradonc.2005.08.001, PII S1053429605000457, Concurrent Radiation/Drug Regimens Current and Horizons
    • G.D. Wilson, S.M. Bentzen, and P.M. Harari Biologic basis for combining drugs with radiation Semin Radiat Oncol 16 2006 2 9 (Pubitemid 41832311)
    • (2006) Seminars in Radiation Oncology , vol.16 , Issue.1 , pp. 2-9
    • Wilson, G.D.1    Bentzen, S.M.2    Harari, P.M.3
  • 8
    • 70449644881 scopus 로고    scopus 로고
    • Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study
    • D. De Ruysscher, C. Dehing, and S.M. Bentzen Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis- generating study Radiother Oncol 93 2009 389 395
    • (2009) Radiother Oncol , vol.93 , pp. 389-395
    • De Ruysscher, D.1    Dehing, C.2    Bentzen, S.M.3
  • 9
    • 0037572347 scopus 로고    scopus 로고
    • CERR: A computational environment for radiotherapy research
    • DOI 10.1118/1.1568978
    • J.O. Deasy, A.I. Blanco, and V.H. Clark CERR: A computational environment for radiotherapy research Med Phys 30 2003 979 985 (Pubitemid 36578702)
    • (2003) Medical Physics , vol.30 , Issue.5 , pp. 979-985
    • Deasy, J.O.1    Blanco, A.I.2    Clark, V.H.3
  • 10
    • 0024317128 scopus 로고
    • Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method
    • G.J. Kutcher, and C. Burman Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method Int J Radiat Oncol Biol Phys 16 1989 1623 1630 (Pubitemid 19154353)
    • (1989) International Journal of Radiation Oncology Biology Physics , vol.16 , Issue.6 , pp. 1623-1630
    • Kutcher, G.J.1    Burman, C.2
  • 11
    • 0022323855 scopus 로고
    • Complication probability as assessed from dose-volume histograms
    • J.T. Lyman Complication probability as assessed from dose-volume histograms Radiat Res Suppl 8 1985 S13 S19
    • (1985) Radiat Res Suppl , vol.8
    • Lyman, J.T.1
  • 12
    • 0027222535 scopus 로고
    • Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation
    • DOI 10.1118/1.597056
    • A. Jackson, G.J. Kutcher, and E.D. Yorke Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation Med Phys 20 1993 613 625 (Pubitemid 23195700)
    • (1993) Medical Physics , vol.20 , Issue.3 , pp. 613-625
    • Jackson, A.1    Kutcher, G.J.2    Yorke, E.D.3
  • 14
  • 15
    • 33747826874 scopus 로고    scopus 로고
    • Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology
    • DOI 10.1038/nrc1950, PII NRC1950
    • S.M. Bentzen Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology Nat Rev Cancer 6 2006 702 713 (Pubitemid 44286002)
    • (2006) Nature Reviews Cancer , vol.6 , Issue.9 , pp. 702-713
    • Bentzen, S.M.1
  • 19
    • 66949173615 scopus 로고    scopus 로고
    • Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma
    • C.A. Kristensen, T.J. Nottrup, and A.K. Berthelsen Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma Radiother Oncol 92 2009 96 99
    • (2009) Radiother Oncol , vol.92 , pp. 96-99
    • Kristensen, C.A.1    Nottrup, T.J.2    Berthelsen, A.K.3
  • 21
    • 0040970499 scopus 로고    scopus 로고
    • A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma
    • V.W. Rusch, K. Rosenzweig, and E. Venkatraman A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J Thorac Cardiovasc Surg 122 2001 788 795
    • (2001) J Thorac Cardiovasc Surg , vol.122 , pp. 788-795
    • Rusch, V.W.1    Rosenzweig, K.2    Venkatraman, E.3
  • 23
    • 76449086135 scopus 로고    scopus 로고
    • Increased oral mucositis after IMRT versus non-IMRT when combined with cetuximab and cisplatin or docetaxel for head and neck cancer: Preliminary results of RTOG 0234
    • D. Khuntia, J. Harris, and S.M. Bentzen Increased oral mucositis after IMRT versus non-IMRT when combined with cetuximab and cisplatin or docetaxel for head and neck cancer: Preliminary results of RTOG 0234 Int J Radiat Oncol Biol Phys 72 Suppl. 2008 S33
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , Issue.SUPPL. , pp. 33
    • Khuntia, D.1    Harris, J.2    Bentzen, S.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.